Abstract
Background
Left bundle branch area pacing (LBBAP) has emerged as an alternative to biventricular pacing (BVP) for cardiac resynchronization therapy (CRT). We aimed to compare the morbidity and mortality associated with LBBAP versus BVP in patients undergoing CRT implantation.
Methods
Consecutive patients who received CRT from two high-volume implantation centers were retrospectively recruited. The primary endpoint was a composite of all-cause death and heart failure hospitalization, and the secondary endpoint was all-cause death.
Results
A total of 491 patients receiving CRT (154 via LBBAP and 337 via BVP) were included, with a median follow-up of 31 months. The primary endpoint was reached by 21 (13.6%) patients in the LBBAP group, as compared with 74 (22.0%) patients in the BVP group [hazard ratio (HR) 0.70, 95% confidence interval (CI) 0.43–1.14, P = 0.15]. There were 10 (6.5%) deaths in the LBBAP group, as compared with 31 (9.2%) in the BVP group (HR 0.91, 95% CI 0.44–1.86, P = 0.79). No significant difference was observed in the risk of either the primary or secondary endpoint between LBBAP and BVP after multivariate Cox regression (HR 0.74, 95% CI 0.45–1.23, P = 0.24, and HR 0.77, 95% CI 0.36–1.67, P = 0.51, respectively) or propensity score matching (HR 0.72, 95% CI 0.41–1.29, P = 0.28, and HR 0.69, 95% CI 0.29–1.65, P = 0.40, respectively).
Conclusion
LBBAP was associated with a comparable effect on morbidity and mortality relative to BVP in patients with indications for CRT.
Highlights
Left bundle branch area pacing (LBBAP) was associated with a comparable effect on morbidity and mortality relative to biventricular pacing (BVP) in patients with indications for cardiac resynchronization therapy (CRT).
LBBAP may serve as a promising alternative to BVP for CRT to improve morbidity and mortality among heart failure patients.
Randomized controlled clinical trials with adequate sample size are justified to confirm these findings.
Similar content being viewed by others
Data Availability
The data underlying this article will be shared on reasonable request to the corresponding author.
References
Cleland JG, Abraham WT, Linde C, et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013;34:3547–56.
Huang W, Wu S, Vijayaraman P, et al. Cardiac Resynchronization Therapy in Patients With Nonischemic Cardiomyopathy Using Left Bundle Branch Pacing. JACC: Clinical Electrophysiol 2020;6:849–58.
Li Y, Yan L, Dai Y, et al. Feasibility and efficacy of left bundle branch area pacing in patients indicated for cardiac resynchronization therapy. Europace 2020;22:ii54-ii60.
Vijayaraman P, Ponnusamy S, Cano Ó, et al. Left Bundle Branch Area Pacing for Cardiac Resynchronization Therapy: Results From the International LBBAP Collaborative Study Group. JACC Clin Electrophysiol. 2021;7:135–47.
Li X, Qiu C, Xie R, et al. Left bundle branch area pacing delivery of cardiac resynchronization therapy and comparison with biventricular pacing. ESC heart failure. 2020;7:1711–22.
Wang Y, Gu K, Qian Z, et al. The efficacy of left bundle branch area pacing compared with biventricular pacing in patients with heart failure: A matched case-control study. J Cardiovasc Electrophysiol. 2020;31:2068–77.
Wu S, Su L, Vijayaraman P, et al. Left Bundle Branch Pacing for Cardiac Resynchronization Therapy: Nonrandomized On-Treatment Comparison With His Bundle Pacing and Biventricular Pacing. Can J Cardiol. 2020;37:319–28.
Chen X, Ye Y, Wang Z, et al. Cardiac resynchronization therapy via left bundle branch pacing vs. optimized biventricular pacing with adaptive algorithm in heart failure with left bundle branch block: a prospective, multi-centre, observational study. Europace 2022;24:807–816.
Sharma PS, Patel NR, Ravi V, et al. Clinical outcomes of left bundle branch area pacing compared to right ventricular pacing: Results from the Geisinger-Rush Conduction System Pacing Registry. Heart Rhythm. 2022;19:3–11.
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.
Regoli F, Scopigni F, Leyva F, et al. Validation of Seattle Heart Failure Model for mortality risk prediction in patients treated with cardiac resynchronization therapy. Eur J Heart Fail. 2013;15:211–20.
Gasparini M, Klersy C, Leclercq C, et al. Validation of a simple risk stratification tool for patients implanted with Cardiac Resynchronization Therapy: the VALID-CRT risk score. Eur J Heart Fail. 2015;17:717–24.
Providencia R, Marijon E, Barra S, et al. Usefulness of a clinical risk score to predict the response to cardiac resynchronization therapy. Int J Cardiol. 2018;260:82–7.
Tokodi M, Schwertner WR, Kovacs A, et al. Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score. Eur Heart J. 2020;41:1747–56.
Gui Y, Ye L, Wu L, Mai H, Yan Q, Wang L. Clinical Outcomes Associated With His-Purkinje System Pacing vs. Biventricular Pacing, in Cardiac Resynchronization Therapy: A Meta-Analysis. Front Cardiovasc Med 2022;9:707148.
Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329–38.
Leyva F, Zegard A, Okafor O, et al. Survival after cardiac resynchronization therapy: results from 50 084 implantations. Europace. 2019;21:754–62.
Hadwiger M, Dagres N, Haug J, et al. Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project. Eur Heart J. 2022;43:2591–9.
Vijayaraman P, Zalavadia D, Haseeb A, et al. Clinical outcomes of conduction system pacing compared to biventricular pacing in patients requiring cardiac resynchronization therapy. Heart Rhythm. 2022;19:1263–71.
McLeod CJ, Shen WK, Rea RF, et al. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy. Heart Rhythm. 2011;8:377–82.
Mullens W, Auricchio A, Martens P, et al. Optimized implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care. Eur J Heart Fail. 2020;22:2349–69.
Funding
This research is supported by the Science and Technology Commission of Shanghai Municipality (No. 19DZ1931002) and Shanghai Clinical Research Center for Interventional Medicine (No. 19MC1910300).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. YL, ZX and XL designed the study; XL, JW, XG, MG, and XC performed the procedure; ZX, ZY, SY, LZ, ML, LP, and XL collected the data; YL, ZX, HL analyzed the data; and YS, WH, and JB performed critical revision and final approval of the study. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics Approval
The study complied with the Declaration of Helsinki and was approved by the local ethics committee (registration number B2022-242R).
Consent to Participate
Written informed consent was obtained from all study participants.
Consent for Publication
Written informed consent was obtained from all study participants.
Conflict of Interest
Hongyang Lu is an employee of Medtronic. All other authors report that they have no relationships to disclose relevant to the contents of this paper.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liang, Y., Xiao, Z., Liu, X. et al. Left Bundle Branch Area Pacing versus Biventricular Pacing for Cardiac Resynchronization Therapy on Morbidity and Mortality. Cardiovasc Drugs Ther (2022). https://doi.org/10.1007/s10557-022-07410-3
Accepted:
Published:
DOI: https://doi.org/10.1007/s10557-022-07410-3